A Canadian biopharmaceutical company that develops treatments for cancer and hormonal diseases soon will create jobs in North Charleston.
Quebec-based Aeterna Zentaris will bring 60 workers through a $1 million investment when it sets up in the SCRA Applied Research Center on International Boulevard near Charleston International Airport.
Operations will start in early to mid-June at the S.C. Research Authority, company spokesman Paul Burroughs said.
The company plans to establish strategic partnerships with the Medical University of South Carolina and other clinical and research centers in the area as part of its ongoing research and development activities. Its pipeline includes compounds at various stages of development.
During the next five years, Aeterna expects to expand its staff to support commercial operations, business development, regulatory and quality assurance, manufacturing management, clinical and product development, as well as various administrative functions.
"Charleston is one of the most thriving and exciting business communities in the United States, and we are looking forward to becoming a part of it," said David Dodd, president and CEO of Aeterna Zentaris.
The SCRA will move this fall to the Nexton development in Summerville to make way for an expansion at the neighboring Boeing South Carolina, which makes 787 jets in North Charleston. The medical research firm intends to transfer its operations to the new SCRA home in October, Burroughs said.
The SCRA currently houses about 150 workers. Though all 60 of the new jobs won't come immediately, SCRA spokeswoman Micki Howard said the current SCRA site or the new Summerville site, when completed, could absorb them.
Reach Warren L. Wise at 937-5524 or twitter.com/warrenlancewise.
Notice about comments:
The Post and Courier is pleased to offer readers the enhanced ability to comment on stories. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We ask that you refrain from profanity, hate speech, personal comments and remarks that are off point.